Compare
iRhythm Holdings, Inc. vs Alphatec Holdings, Inc. vs Orthofix Medical Inc. vs NovoCure Ltd
| Latest fiscal year | iRhythm Holdings, Inc. IRTC | Alphatec Holdings, Inc. ATEC | Orthofix Medical Inc. OFIX | NovoCure Ltd NVCR |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $747.14M | $764.15M | $822.31M | $655.35M |
| Revenue growth (YoY) | +26.2% | +25.0% | +2.9% | +8.3% |
| Gross margin | 70.6% | 69.6% | 68.8% | 74.5% |
| Operating margin | -7.7% | -10.7% | -9.9% | -23.5% |
| Net margin | -6.0% | -18.8% | -11.2% | -20.8% |
| Net income | -$44.55M | -$143.36M | -$92.19M | -$136.23M |
| EPS (Diluted) | -$1.39 | -$0.96 | -$2.33 | -$1.22 |
| Operating cash flow | $80.86M | $45.23M | $33.35M | -$49.03M |
| Free cash flow | $34.52M | $2.78M | -$1.28M | -$75.68M |
| Cash & equivalents | $236.01M | $160.81M | $82.03M | $93.55M |
| Total assets | $1.02B | $791.21M | $850.65M | $804.33M |
| Total liabilities | $867.30M | n/a | $400.61M | $463.86M |
| Shareholders' equity | $152.75M | $12.43M | $450.04M | $340.47M |
| Return on year-end equity | -29.2% | n/m | -20.5% | -40.0% |
| Shares outstanding | 32.30M | 150.26M | 39.83M | 112.49M |
Revenue, most recent five fiscal years
| Fiscal year | iRhythm Holdings, Inc. | Alphatec Holdings, Inc. | Orthofix Medical Inc. | NovoCure Ltd |
|---|---|---|---|---|
| Latest | $747.14M Ended 2025-12-31 | $764.15M Ended 2025-12-31 | $822.31M Ended 2025-12-31 | $655.35M Ended 2025-12-31 |
| 1 year earlier | $591.84M Ended 2024-12-31 | $611.56M Ended 2024-12-31 | $799.49M Ended 2024-12-31 | $605.22M Ended 2024-12-31 |
| 2 years earlier | $492.68M Ended 2023-12-31 | $482.26M Ended 2023-12-31 | $746.64M Ended 2023-12-31 | $509.34M Ended 2023-12-31 |
| 3 years earlier | $410.92M Ended 2022-12-31 | $350.87M Ended 2022-12-31 | $460.71M Ended 2022-12-31 | $537.84M Ended 2022-12-31 |
| 4 years earlier | $322.82M Ended 2021-12-31 | $243.21M Ended 2021-12-31 | $464.48M Ended 2021-12-31 | $535.03M Ended 2021-12-31 |